CANNABIS BIOSCI INTL HLDG (CBIH) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 90 226 sessions, September 30, 2025 to September 30, 2026
- Largest daily move
- +100% close of July 10, 2026
- 1-year change
- -50% closing prices, September 30, 2025 to September 30, 2026
- 1-month change
- +100% closing prices, August 28, 2026 to September 30, 2026
Company Description
CANNABIS BIOSCI INTL HLDG (OTC: CBIH) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $2.3M.
CBIH has declined 50.0% over the past year. The last closing price was $0.0002.
For FY2025, CANNABIS BIOSCI INTL HLDG reported revenue of $303K with net income of -$549K and diluted earnings per share of $0.00. The company operates at a net profit margin of -181.1%.
This page collects what Stock Titan holds for CBIH, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
CANNABIS BIOSCI INTL HLDG (CBIH) closed at $0.0002 on September 30, 2026. Over the past 12 months, the price has lost 50.0%.
CBIH Metrics & Rankings
Price returns through September 30, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CANNABIS BIOSCI INTL HLDG has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 0 with negative movement. Key topics include partnership, clinical trial, conferences. View all CBIH news →
SEC Filings
CANNABIS BIOSCI INTL HLDG has filed 9 recent SEC filings, including 3 Form 10-Q, 3 Form NT 10-Q, 1 Form 144, 1 Form NT 10-K. The most recent filing was submitted on August 31, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CBIH SEC filings →
Financial Highlights
CANNABIS BIOSCI INTL HLDG generated $303K in revenue in FY2025, retaining a 86.8% gross margin, operating income reached -$421K (-139.1% operating margin), and net income was -$549K, reflecting a -181.1% net profit margin. Diluted earnings per share stood at $0.00. The company generated -$330K in operating cash flow. The current ratio was 0.03, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in CANNABIS BIOSCI INTL HLDG (CBIH) currently stands at 10.0 thousand shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since November 2025, short interest has increased by 99900.0%.
Days to Cover History
Days to cover for CANNABIS BIOSCI INTL HLDG (CBIH) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
CBIH Company Profile & Sector Positioning
CANNABIS BIOSCI INTL HLDG (CBIH) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CBIH often look at related companies in the same sector, including MARIJUANA INC (MAJI), FILAMENT HEALTH CORP (FLHLF), CRESCITA THERAPEUTICS (CRRTF), REVIVE THERAPEUTICS LTD (RVVTF), and PHARMACIELO LTD (PCLOF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CBIH's relative position within its industry.